Price Jackson

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

Michael S. Hofman, John Violet, Rodney J. Hicks et al. · The Lancet Oncology · 2018 · 1.1K citations

Dosimetry of ¹⁷⁷Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes

John Violet, Price Jackson, Justin Ferdinandus et al. · Journal of Nuclear Medicine · 2018 · 454 citations · Full text

Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy

Wan Nordiana Rahman, Nour Bishara, Trevor Ackerly et al. · Nanomedicine Nanotechnology Biology and Medicine · 2009 · 361 citations

Nanoparticles, Nanomedicine, Engineering +12

Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of ¹⁷⁷Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer

John Violet, Shahneen Sandhu, Amir Iravani et al. · Journal of Nuclear Medicine · 2019 · 269 citations · Full text

Fast and Low-GPU-memory abdomen CT organ segmentation: The FLARE challenge

Jun Ma, Yao Zhang, Song Gu et al. · Medical Image Analysis · 2022 · 151 citations · Full text

Computed Tomography, Image Analysis, Engineering +12